ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Passes Above 50-Day Moving Average - Here's What Happened

Key Points

• CHRN briefly moved above its 50-day moving average of $21.37, reaching $22.47, before last trading at $19.39; the stock was reported down 7.4%.
• The company reported a quarterly loss of $3.89 per share on $18.09 million in revenue, with a negative net margin of 135.66% and negative return on equity of 197.81%.
• Institutional ownership stands at 6.42%, with firms including Geode Capital Management increasing holdings and J. Safra Asset Management establishing a roughly $1.1 million position.

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN - Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $21.37 and traded as high as $22.47. ChronoScale Corporation Common Stock shares last traded at $19.39, with a volume of 361,135 shares.

ChronoScale Corporation Common Stock Stock Down 7.4%

The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The company has a market cap of $69.03 million, a P/E ratio of -3.60 and a beta of 1.00. The company has a fifty day moving average of $21.37 and a 200 day moving average of $14.93.

ChronoScale Corporation Common Stock (NASDAQ:CHRN - Get Free Report) last posted its quarterly earnings data on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The firm had revenue of $18.09 million for the quarter. On average, research analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

Hedge funds and other institutional investors have recently made changes to their positions in the business. Citadel Advisors LLC purchased a new position in shares of ChronoScale Corporation Common Stock in the third quarter worth approximately $198,000. Geode Capital Management LLC increased its holdings in ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company's stock valued at $218,000 after buying an additional 10,281 shares during the last quarter. J.Safra Asset Management Corp bought a new position in ChronoScale Corporation Common Stock in the second quarter worth approximately $1,085,000. Shay Capital LLC bought a new position in ChronoScale Corporation Common Stock in the third quarter worth approximately $67,000. Finally, Virtu Financial LLC purchased a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth $57,000. Hedge funds and other institutional investors own 6.42% of the company's stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc NASDAQ: EKSO is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source